AstraZeneca-Funded Non-Clinical PhD studentships (2023 intake) Expression of Interest (Deadline: 22nd August 2022)

Image for AstraZeneca-Funded Non-Clinical PhD studentships (2023 intake) Expression of Interest (Deadline: 22nd August 2022)

Remit: The aim of this programme is to fund 3.5 year Non-Clinical PhD studentships at the University of Cambridge (UoC) for talented graduates in research areas which align with the strategic interests of AstraZeneca (AZ). These areas of interest are in research priorities of the Biologics Engineering, Discovery Sciences, Oncology Machine Learning & AI, Data Sciences & AI, Global Chemistry Network, Biopharmaceutical development, Early cardiovascular, renal and metabolic therapy areas, Clinical Pharmacology and Safety Sciences, Respiratory and Immunology research areas at AstraZeneca. Further details on the areas of interest could be found in Appendix 1 of the Expression of Interest form.

Eligibility: Principal Investigators employed by the University of Cambridge and AstraZeneca are eligible to apply in partnership or as individuals. Individual investigators applying without an AstraZeneca / Cambridge partner must be willing to collaborate with a co-investigator from the partner organisation. The programme management team can assist with the identification of a suitable partner, please see below for programme management contact details. Please get in touch with the UoC programme manager by 01st August 2022 if you require to identify a suitable partner.

All applications should be submitted as a partnership between identified Principle investigators employed by the UoC and AZ. The University of Cambridge Principal Investigator will be the lead investigator for this studentship should it be awarded. Support for the proposal will be required from the relevant University of Cambridge Head of Department prior to submission.

Funding: Each funded studentship covers 

Please note, the AstraZeneca funded non clinical studentship program covers academic fees for UK/home students only. Any additional funding required for the recruitment of overseas students will not be covered and will have to be met by the University department or other sources.

Review: Proposals will be reviewed by the Steering Committee which includes representation from AstraZeneca and the University of Cambridge. The Committee will be responsible annual allocation of studentships based on proposal fit to strategic remit, the enhanced collaborative potential of the proposal, and available budgets.

Deadline: The deadline for receipt of full proposals is Monday 22nd August 2022.  As timelines are quite tight, PIs are strongly encouraged to seek a collaborative partner as soon as possible (and prior to 01st Aug 2022) so that full submissions can be made to the selection committee by the specified deadline. 

Contact details: All proposals should be submitted by email to the programme managers:

Posted on 29/07/2022